drugset / Trial / NCT01315158

Propofol vs Propofol + Benzo/Opiates in High Risk Group

NCT01315158

RandomizedParallel-groupSingle-blindTreatment

Summary

This will be a randomized controlled trial that compares the rates of sedation related complications in high risk patients (ASA greater or equal to 3, BMI greater or equal to 30, those at risk for OSA) undergoing advanced endoscopy procedures with propofol alone compared to propofol in combination with benzodiazepines and opioids.

Timeline

Start
2011-01
Primary completion
2014-07
Completion
2014-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 0.5 ug/kg
Subject Fentanyl Other / unclassified 1 ug/kg
Subject Midazolam Small molecule 1 mg
Subject Midazolam Small molecule 1.5 mg
Subject Midazolam Small molecule 2 mg
Comparator Propofol Small molecule 0.1 mg/kg
Comparator Propofol Small molecule 0.2 mg/kg